Current Rheumatology Reports

, Volume 4, Issue 2, pp 143–149 | Cite as

Control of connective tissue gene expression by TGFβ: Role of smad proteins in fibrosis

  • Franck Verrecchia
  • Alain Mauviel
Article

Abstract

Transforming growth factor-beta (TGFβ) plays a critical role in the development of tissue fibrosis. Its expression is consistently elevated in affected organs and correlates with increased extracellular matrix deposition. During the last few years, tremendous progress has been made in understanding the molecular aspects of intracellular signaling downstream of the TGFβ receptors. In particular, Smad proteins—TGFβ receptor kinase substrates that translocate into the cell nucleus to act as transcription factors—have been studied extensively. Their role in the modulation of extracellular matrix gene expression is discussed in this review.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References and Recommended Reading

  1. 1.
    Roberts AB: Molecular and cell biology of TGF-beta. Miner Electrolyte Metab 1998, 24:111–119.PubMedCrossRefGoogle Scholar
  2. 2.
    Massagué J: TGF-beta signal transduction. Annu Rev Biochem 1998, 67:753–791.PubMedCrossRefGoogle Scholar
  3. 3.
    Piek E, Heldin CH, Ten Dijke P: Specificity, diversity, and regulation in TGF-beta superfamily signaling. FASEB J 1999, 13:2105–2124.PubMedGoogle Scholar
  4. 4.
    Massagué J, Wotton D: Transcriptional control by the TGFbeta/ Smad signaling system. EMBO J 2000, 19:1745–1754.PubMedCrossRefGoogle Scholar
  5. 5.
    Tsukazaki T, Chiang TA, Davison AF, et al.: SARA, a FYVE domain protein that recruits Smad2 to the TGFbeta receptor. Cell 1998, 95:779–791.PubMedCrossRefGoogle Scholar
  6. 6.
    Lo RS, Massagué J: Ubiquitin-dependent degradation of TGFbeta-activated Smad2. Nat Cell Biol 1999, 1:472–478.PubMedCrossRefGoogle Scholar
  7. 7.
    Nakao A, Afrakhte M, Moren A, et al.: Identification of Smad7, a TGFbeta-inducible antagonist of TGF-beta signalling. Nature 1997, 389:631–635. This study characterizes the first described inhibitory Smad, Smad7, capable of binding activated TβRI, thereby preventing R-Smad phosphorylation and downstream signaling.PubMedCrossRefGoogle Scholar
  8. 8.
    Imamura T, Takase M, Nishihara A, et al.: Smad6 inhibits signalling by the TGF-beta superfamily. Nature 1997, 389:622–626.PubMedCrossRefGoogle Scholar
  9. 9.
    Kim J, Johnson K, Chen HJ, et al.: Drosophila mad binds to DNA and directly mediates activation of vestigial by Decapentaplegic. Nature 1997, 388:304–308.PubMedCrossRefGoogle Scholar
  10. 10.
    Labbé E, Silvestri C, Hoodless PA, et al.: Smad2 and Smad3 positively and negatively regulate TGF beta-dependent transcription through the forkhead DNA-binding protein FAST2. Mol Cell 1998, 2:109–120.PubMedCrossRefGoogle Scholar
  11. 11.
    Vindevoghel L, Lechleider RJ, Kon A, et al.: SMAD3/4-dependent transcriptional activation of the human type VII collagen gene (COL7A1) promoter by transforming growth factor beta. Proc Natl Acad Sci U S A 1998, 95:14769–14774.PubMedCrossRefGoogle Scholar
  12. 12.
    Vindevoghel L, Kon A, Lechleider RJ, et al.: Smad-dependent transcriptional activation of human type VII collagen gene (COL7A1) promoter by transforming growth factor-beta. J Biol Chem 1998, 273:13053–13057.PubMedCrossRefGoogle Scholar
  13. 13.
    Dennler S, Itoh S, Vivien D, et al.: Direct binding of Smad3 and Smad4 to critical TGF beta-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene. EMBO J 1998, 17:3091–3100.PubMedCrossRefGoogle Scholar
  14. 14.
    Jonk LJ, Itoh S, Heldin CH, et al.: Identification and functional characterization of a Smad binding element (SBE) in the JunB promoter that acts as a transforming growth factorbeta, activin, and bone morphogenetic protein-inducible enhancer. J Biol Chem 1998, 273:21145–21152.PubMedCrossRefGoogle Scholar
  15. 15.
    Wong C, Rougier-Chapman EM, Frederick JP, et al.: Smad3-Smad4 and AP-1 complexes synergize in transcriptional activation of the c-Jun promoter by transforming growth factor beta. Mol Cell Biol 1999, 19:1821–1830.PubMedGoogle Scholar
  16. 16.
    Yagi K, Goto D, Hamamoto T, et al.: Alternatively spliced variant of Smad2 lacking exon 3: comparison with wild-type Smad2 and Smad3. J Biol Chem 1999, 274:703–709.PubMedCrossRefGoogle Scholar
  17. 17.
    Zawel L, Dai JL, Buckhaults P, et al.: Human Smad3 and Smad4 are sequence-specific transcription activators. Mol Cell 1998, 1:611–617. This study identifies the optimal DNA stretch, CAGACA, binding recombinant MH1 domains of Smad3 and Smad4 with the highest affinity.PubMedCrossRefGoogle Scholar
  18. 18.
    Moustakas A, Kardassis D: Regulation of the human p21/ WAF1/Cip1 promoter in hepatic cells by functional interactions between Sp1 and Smad family members. Proc Natl Acad Sci U S A 1998, 95:6733–6738.PubMedCrossRefGoogle Scholar
  19. 19.
    Hua X, Liu X, Ansari DO, Lodish HF: Synergistic cooperation of TFE3 and Smad proteins in TGF-beta-induced transcription of the plasminogen activator inhibitor-1 gene. Genes Dev 1998, 12:3084–3095.PubMedGoogle Scholar
  20. 20.
    Zhang Y, Feng XH, Derynck R: Smad3 and Smad4 cooperate with c-Jun/c-Fos to mediate TGF-beta-induced transcription. Nature 1998, 394:909–913.PubMedCrossRefGoogle Scholar
  21. 21.
    Verrecchia F, Vindevoghel L, Lechleider RJ, et al.: Smad3/AP-1 interactions control transcriptional responses to TGF-beta in a promoter-specific manner. Oncogene 2001, 20:3332–3340. This report presents a thorough analysis of the functional interactions between the Smad and AP-1 transactivation pathways. The outcome for this interaction depends on the target genes, where Smad-dependent transcription is blocked by AP-1, whereas AP-1-driven transcription is further activated by Smad.PubMedCrossRefGoogle Scholar
  22. 22.
    Chen X, Weisberg E, Fridmacher V, et al.: Smad4 and FAST-1 in the assembly of activin-responsive factor. Nature 1997, 389:85–89.PubMedCrossRefGoogle Scholar
  23. 23.
    Liu B, Dou CL, Prabhu L, Lai E: FAST-2 is a mammalian winged-helix protein which mediates transforming growth factor beta signals. Mol Cell Biol 1999, 19:424–430.PubMedGoogle Scholar
  24. 24.
    Yanagisawa J, Yanagi Y, Masuhiro Y, et al.: Convergence of transforming growth factor-beta and vitamin D signaling pathways on SMAD transcriptional coactivators. Science 1999, 283:1317–1321.PubMedCrossRefGoogle Scholar
  25. 25.
    Germain S, Howell M, Esslemont GM, Hill CS: Homeodomain and winged-helix transcription factors recruit activated Smads to distinct promoter elements via a common Smad interaction motif. Genes Dev 2000, 14:435–451.PubMedGoogle Scholar
  26. 26.
    Workman JL, Kingston RE: Alteration of nucleosome structure as a mechanism of transcriptional regulation. Annu Rev Biochem 1998, 67:545–579.PubMedCrossRefGoogle Scholar
  27. 27.
    Snowden AW, Perkins ND: Cell cycle regulation of the transcriptional coactivators p300 and CREB binding protein. Biochem Pharmacol 1998, 55:1947–1954.PubMedCrossRefGoogle Scholar
  28. 28.
    Nishihara A, Hanai JI, Okamoto N, et al.: Role of p300, a transcriptional coactivator, in signalling of TGF-beta. Genes Cells 1998, 3:613–623.PubMedCrossRefGoogle Scholar
  29. 29.
    Janknecht R, Wells NJ, Hunter T: TGF-beta-stimulated cooperation of Smad proteins with the coactivators CBP/p300. Genes Dev 1998, 12:2114–2119.PubMedGoogle Scholar
  30. 30.
    Shen X, Hu PP, Liberati NT, et al.: TGF-beta-induced phosphorylation of Smad3 regulates its interaction with coactivator p300/CREB-binding protein. Mol Biol Cell 1998, 9:3309–3319.PubMedGoogle Scholar
  31. 31.
    Feng XH, Zhang Y, Wu RY, Derynck R: The tumor suppressor Smad4/DPC4 and transcriptional adaptor CBP/p300 are coactivators for smad3 in TGF-beta-induced transcriptional activation. Genes Dev 1998, 12:2153–2163.PubMedGoogle Scholar
  32. 32.
    Bitzer M, von Gersdorff G, Liang D, et al.: A mechanism of suppression of TGF-beta/SMAD signaling by NF-kappa B/RelA. Genes Dev 2000, 14:187–197.PubMedGoogle Scholar
  33. 33.
    Ghosh AK, Yuan W, Mori Y, Varga J: Smad-dependent stimulation of type I collagen gene expression in human skin fibroblasts by TGF-beta involves functional cooperation with p300/CBP transcriptional coactivators. Oncogene 2000, 19:3546–3555.PubMedCrossRefGoogle Scholar
  34. 34.
    Verrecchia F, Pessah M, Atfi A, Mauviel A: Tumor necrosis factor-alpha inhibits transforming growth factor-beta/Smad signaling in human dermal fibroblasts via AP-1 activation. J Biol Chem 2000, 275:30226–30231.PubMedCrossRefGoogle Scholar
  35. 35.
    Chung KY, Agarwal A, Uitto J, Mauviel A: An AP-1 binding sequence is essential for regulation of the human alpha2(I) collagen (COL1A2) promoter activity by transforming growth factor-beta. J Biol Chem 1996, 271:3272–3278. This study identifies the minimal TGFβ response element (TβRE) within the region -271/-235 of the human COL1A2 promoter. It also clearly demonstrates that Sp1 sites upstream of the TβRE are not required for TGFβ response.PubMedCrossRefGoogle Scholar
  36. 36.
    Ghosh AK, Yuan W, Mori Y, et al.: Antagonistic regulation of type I collagen gene expression by interferon-gamma and transforming growth factor-beta: integration at the level of p300/CBP transcriptional coactivators. J Biol Chem 2001, 276:11041–11048. This study provides the demonstration for a key role of the transcriptional co-activator p300 in regulating type I collagen gene expression and regulation by TGFβ and IFNã.PubMedCrossRefGoogle Scholar
  37. 37.
    Nishihara A, Hanai J, Imamura T, et al.: E1A inhibits transforming growth factor-beta signaling through binding to Smad proteins. J Biol Chem 1999, 274:28716–28723.PubMedCrossRefGoogle Scholar
  38. 38.
    Akiyoshi S, Inoue H, Hanai J, et al.: c-Ski acts as a transcriptional co-repressor in transforming growth factor-beta signaling through interaction with Smads. J Biol Chem 1999, 274:35269–35277.PubMedCrossRefGoogle Scholar
  39. 39.
    Wotton D, Lo RS, Swaby LA, Massagué J: Multiple modes of repression by the Smad transcriptional corepressor TGIF. J Biol Chem 1999, 274:37105–37110.PubMedCrossRefGoogle Scholar
  40. 40.
    Verrecchia F, Chu ML, Mauviel A: Identification of novel TGFbeta/ Smad gene targets in dermal fibroblasts using a combined cDNA microarray/promoter transactivation approach. J Biol Chem 2001, 276:17058–17062. This work demonstrates that all fibrillar collagen genes expressed by fibroblasts are direct Smad targets downstream of TGFβ. It also identifies approximately 60 immediate-early induced genes downstream of TGFβ.PubMedCrossRefGoogle Scholar
  41. 41.
    Chen SJ, Yuan W, Mori Y, et al.: Stimulation of type I collagen transcription in human skin fibroblasts by TGF-beta: involvement of Smad 3. J Invest Dermatol 1998, 112:49–57.CrossRefGoogle Scholar
  42. 42.
    Lai CF, Feng X, Nishimura R, et al.: Transforming growth factorbeta up-regulates the beta 5 integrin subunit expression via Sp1 and Smad signaling. J Biol Chem 2000, 275:36400–36406.PubMedCrossRefGoogle Scholar
  43. 43.
    Hocevar BA, Brown TL, Howe PH: TGF-beta induces fibronectin synthesis through a c-Jun N-terminal kinase-dependent, Smad4-independent pathway. EMBO J 1999, 18:1345–1356. This study identifies fibronectin as a JNK-dependent, Smad4-independent, target downstream of the TGFβ receptors. This study establishes the importance of non-Smad pathways in mediating TGFβ biologic activities with regard to ECM gene expression.PubMedCrossRefGoogle Scholar
  44. 44.
    Inagaki Y, Truter S, Ramirez F: Transforming growth factorbeta stimulates alpha 2(I) collagen gene expression through a cis-acting element that contains an Sp1-binding site. J Biol Chem 1994, 269:14828–14834.PubMedGoogle Scholar
  45. 45.
    Kouba DJ, Chung KY, Nishiyama T, et al.: Nuclear factor-kappa B mediates TNF-alpha inhibitory effect on alpha 2(I) collagen (COL1A2) gene transcription in human dermal fibroblasts. J Immunol 1999, 162:4226–4234.PubMedGoogle Scholar
  46. 46.
    Zhang W, Ou J, Inagaki Y, et al.: Synergistic cooperation between Sp1 and Smad3.Smad4 mediates transforming growth factor beta1 stimulation of alpha 2(I)-collagen (COL1A2) transcription. J Biol Chem 2000, 275:39237–39245.PubMedCrossRefGoogle Scholar
  47. 47.
    Roberts AB, Sporn MB: Physiological actions and clinical applications of transforming growth factor-beta (TGF-beta). Growth Factors 1993, 8:1–9.PubMedCrossRefGoogle Scholar
  48. 48.
    Ashcroft GS, Yang X, Glick AB, et al.: Mice lacking Smad3 show accelerated wound healing and an impaired local inflammatory response. Nat Cell Biol 1999, 1:260–266. The authors demonstrate accelerated wound healing in Smad3 knockout mice. These paradoxic results are explained by increased reepithelialization and reduced monocytic infiltration at the wound site. In these mice, exogenously added TGFβ could enhance collagen expression, indicating Smad-independent regulation of ECM deposition by TGFβ in vivo.PubMedCrossRefGoogle Scholar
  49. 49.
    Kähäri VM, Vuorio T, Nanto-Salonen K, Vuorio E: Increased type I collagen mRNA levels in cultured scleroderma fibroblasts. Biochim Biophys Acta 1984, 781:183–186.PubMedGoogle Scholar
  50. 50.
    Ohta A, Uitto J: Procollagen gene expression by scleroderma fibroblasts in culture. Inhibition of collagen production and reduction of pro alpha 1(I) and pro alpha 1(III) collagen messenger RNA steady-state levels by retinoids. Arthritis Rheum 1987, 30:404–411.PubMedCrossRefGoogle Scholar
  51. 51.
    Jimenez SA, Saitta B: Alterations in the regulation of expression of the alpha 1(I) collagen gene (COL1A1) in systemic sclerosis (scleroderma). Springer Semin Immunopathol 1999, 21:397–414.PubMedGoogle Scholar
  52. 52.
    Uitto J, Kouba D: Cytokine modulation of extracellular matrix gene expression: relevance to fibrotic skin diseases. J Dermatol Sci 2000, 24:S60-S69.PubMedCrossRefGoogle Scholar
  53. 53.
    Holmes A, Abraham DJ, Sa S, et al.: CTGF and SMADs, maintenance of scleroderma phenotype is independent of SMAD signaling. J Biol Chem 2001, 276:10594–10601.PubMedCrossRefGoogle Scholar
  54. 54.
    Serini G, Gabbiani G: Mechanisms of myofibroblast activity and phenotypic modulation. Exp Cell Res 1999, 250:273–283.PubMedCrossRefGoogle Scholar
  55. 55.
    Reisdorf P, Lawrence DA, Sivan V, et al.: Alteration of transforming growth factor-beta1 response involves downregulation of Smad3 signaling in myofibroblasts from skin fibrosis. Am J Pathol 2001, 159:263–272. In a pig model of ã-irradiation-induced skin fibrosis, myofibroblasts exhibit a lack of TGFβ growth inhibition and impaired Smad signaling. The latter inactivation of Smad3 allows hyperproliferation of myofibroblasts in the fibrotic environment with high TGFβ concentrations.PubMedGoogle Scholar
  56. 56.
    Feng XH, Lin X, Derynck R: Smad2, Smad3 and Smad4 cooperate with Sp1 to induce p15(Ink4B) transcription in response to TGF-beta. EMBO J 2000, 19:5178–5193.PubMedCrossRefGoogle Scholar
  57. 57.
    Geiser AG, Busam KJ, Kim SJ, et al.: Regulation of the transforming growth factor-beta 1 and-beta 3 promoters by transcription factor Sp1. Gene 1993, 129:223–228.PubMedCrossRefGoogle Scholar
  58. 58.
    Verrecchia F, Rossert J, Mauviel A: Blocking Sp1 transcription factor broadly inhibits extracellular matrix gene expression in vitro and in vivo: implications for the treatment of tissue fibrosis. J Invest Dermatol 2001, 116:755–763. This study uses various means of interfering with Sp1 activity in vitro and in vivo. The results, using cDNA microarrays and promoter transactivation assays, indicate the potential for this approach to reduce the expression of numerous ECM genes simultaneously.PubMedCrossRefGoogle Scholar

Copyright information

© Current Science Inc 2002

Authors and Affiliations

  • Franck Verrecchia
    • 1
  • Alain Mauviel
    • 1
  1. 1.INSERM U532, Institut de Recherche sur la Peau, Pavillon BazinHôpital Saint-LouisParisFrance

Personalised recommendations